Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Exane BNP Paribas Downgrades Novartis to Neutral

Exane BNP Paribas analyst Richard Parkes downgrades Novartis (NYSE:NVS) from Outperform to Neutral.
byBenzinga Newsdesk
December 6, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Exane BNP Paribas analyst Richard Parkes downgrades Novartis (NYSE:NVS) from Outperform to Neutral.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0